News Archives
SENOMYX, INC. LICENSES SODIUM CHANNEL TECHNOLOGY FROM JOHNS HOPKINS UNIVERSITY
LA JOLLA (May 9, 2000) – Senomyx, Inc. announced today that it has acquired rights to novel sodium channel related technology developed in the laboratories of Dr. Solomon Snyder at Johns Hopkins University. This patented discovery (U.S. Patent 5,693,756) identifies new forms of an amiloride sensitive sodium channel and new possible methods of identifying substances which stimulate or block salty taste perception. "We are glad to have this technology in our portfolio to strengthen our discovery program in the area of salty taste," said Dr. Lubert Stryer, Chief Scientific Officer and Chairman of the Board. Paul A. Grayson, President and Chief Executive Officer said, "Salt perception is another example of an exciting area of consumer product opportunity that we plan to pursue."
Senomyx is dedicated to becoming the world leader in the discovery and commercialization of products and services relevant to the biology, genomics, and chemistry of chemosensation in a broad range of markets including consumer food, fragrance, cosmetic, therapeutic, household, agricultural, and industrial applications. The Company is assembling a matrix of technologies including proprietary chemoreceptors involved in the detection, quantification, signal transduction, and perception of mediators and modulators of taste, olfaction, and other sensory modalities. Senomyx has exclusive agreements with Harvard University, Johns Hopkins University, Rockefeller University, and the University of California regarding various enabling technologies in the field of chemosensation. Senomyx will utilize a range of recent advances in cellular and molecular biology, genomics, combinatorial chemistry, biomolecular screening, informatics, and other areas to create the first consumer genomics company. These technologies, developed to their full potential, will enrich the quality of life for consumers.
back to News Archives